Literature DB >> 23621844

Prolongation of QTc intervals and risk of death among patients with sickle cell disease.

Bharathi Upadhya1, William Ntim, Richard Brandon Stacey, Rick Henderson, David Leedy, Francis X O'Brien, Mary Ann Knovich.   

Abstract

BACKGROUND: Unexplained sudden death is common among patients with sickle cell diseases (SCD). QTc prolongation is a risk factor for fatal arrhythmias among adults. This study sought to identify the predictors for QTc prolongation and determine whether QTc prolongation is associated with increased mortality in patients with SCD.
METHODS: We reviewed the electrocardiograms (EKG) and the transthoracic echocardiograms (TTE) of 140 consecutive adults (>18 years) with SCD from October 1996 to January of 2012. QTc prolongation was categorized into three gender-specific categories based on previous publications. Stepwise regression was performed to evaluate QTc interval and mortality as dependent variables. Hemolytic burden as reflected in laboratory evaluation, diastolic, and systolic TTE variables were included in this model.
RESULTS: In a stepwise regression analysis, only increased tricuspid regurgitant jet velocity (TRV) (r = 0.483, P = 0.015) had a significant association with QTc interval. Among 49 (35%) patients, the QTc interval was persistently prolonged (PP) (>450 ms in men, >470 ms in women). Twenty-one patients (15%) died over 9 years of follow-up. PP QTc was associated with increased mortality (HR; 8.3 with 95% CI: 2.8-24.6, P < 0.001) compared with normal QTc. In stepwise regression analysis, along with increased TRV (P = 0.005) and acute chest syndrome (P < 0.001), prolonged QTc (P = 0.004) was independently associated with increased mortality.
CONCLUSION: Prolonged QTc among the patients with SCD is an independent risk factor for increased mortality.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  acute chest syndrome; prolongation of QTc; pulmonary hypertension; sickle cell disease; sudden death

Mesh:

Substances:

Year:  2013        PMID: 23621844     DOI: 10.1111/ejh.12127

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  13 in total

1.  Association of sickle cell trait with atrial fibrillation: The REGARDS cohort.

Authors:  Daniel R Douce; Elsayed Z Soliman; Rakhi Naik; Hyacinth I Hyacinth; Mary Cushman; Cheryl A Winkler; George Howard; Ethan M Lange; Leslie A Lange; Marguerite R Irvin; Neil A Zakai
Journal:  J Electrocardiol       Date:  2019-04-16       Impact factor: 1.438

2.  Reversal of a rheologic cardiomyopathy following hematopoietic stem cell transplantation for sickle cell disease.

Authors:  Vandana Sachdev; Matthew Hsieh; Neal Jeffries; Anna Noreuil; Wen Li; Stanislav Sidenko; Hwaida Hannoush; Emily Limerick; Delon Wilson; John Tisdale; Courtney Fitzhugh
Journal:  Blood Adv       Date:  2019-10-08

3.  IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias.

Authors:  Akash Gupta; Yu-Dong Fei; Tae Yun Kim; An Xie; Ken Batai; Ian Greener; Haiyang Tang; Sultan Ciftci-Yilmaz; Elizabeth Juneman; Julia H Indik; Guanbin Shi; Jared Christensen; Geetanjali Gupta; Cheryl Hillery; Mayank M Kansal; Devang S Parikh; Tong Zhou; Jason X-J Yuan; Yogendra Kanthi; Peter Bronk; Gideon Koren; Rick Kittles; Julio D Duarte; Joe G N Garcia; Roberto F Machado; Samuel C Dudley; Bum-Rak Choi; Ankit A Desai
Journal:  Blood       Date:  2021-03-04       Impact factor: 25.476

Review 4.  Mechanisms linking red blood cell disorders and cardiovascular diseases.

Authors:  Ioana Mozos
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  Associations of Prolonged QTc in Sickle Cell Disease.

Authors:  Julia H Indik; Vineet Nair; Ruslan Rafikov; Iwan S Nyotowidjojo; Jaskanwal Bisla; Mayank Kansal; Devang S Parikh; Melissa Robinson; Anand Desai; Megha Oberoi; Akash Gupta; Taimur Abbasi; Zain Khalpey; Amit R Patel; Roberto M Lang; Samuel C Dudley; Bum-Rak Choi; Joe G N Garcia; Roberto F Machado; Ankit A Desai
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

6.  Plasma homocysteine levels associated with a corrected QT interval.

Authors:  Zhao Li; Xiaofan Guo; Guozhe Sun; Liqiang Zheng; Yingxian Sun; Yamin Liu; Maria Roselle Abraham
Journal:  BMC Cardiovasc Disord       Date:  2017-07-11       Impact factor: 2.298

7.  Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe.

Authors:  Poulami Maitra; Melissa Caughey; Laura Robinson; Payal C Desai; Susan Jones; Mehdi Nouraie; Mark T Gladwin; Alan Hinderliter; Jianwen Cai; Kenneth I Ataga
Journal:  Haematologica       Date:  2017-01-19       Impact factor: 9.941

8.  QT interval variations and mortality risk: is there any relationship?

Authors:  Ciprian Rezuş; Victor Dan Moga; Anca Ouatu; Mariana Floria
Journal:  Anatol J Cardiol       Date:  2015-03       Impact factor: 1.596

Review 9.  Cardiac pathophysiology in sickle cell disease.

Authors:  Oluwabukola Temitope Gbotosho; Michael Taylor; Punam Malik
Journal:  J Thromb Thrombolysis       Date:  2021-03-07       Impact factor: 2.300

10.  Does Anemia Cause QT Prolongation in Patients with Hematologic Disorders?

Authors:  Yu-Dong Fei; Yi-Gang Li; William Surkis; Li Zhang
Journal:  Chin Med J (Engl)       Date:  2015-12-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.